Åse Hagen Morsund

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 458 citations

Thrombosis, Endpoint Trial, Tenecteplase Versus Alteplase +13

The development of cognitive and emotional impairment after a minor stroke: A longitudinal study

Åse Hagen Morsund, Hanne Ellekjær, Arne Gramstad et al. · Acta Neurologica Scandinavica · 2019 · 46 citations · Full text

Stroke risk after transient ischemic attack in a Norwegian prospective cohort

Fredrik Ildstad, Hanne Ellekjær, Torgeir Wethal et al. · BMC Neurology · 2019 · 22 citations · Full text

Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study

Cathrine Goberg Olsen, Øyvind L. Busk, Tori Navestad Aanjesen et al. · Neuroepidemiology · 2022 · 20 citations · Full text

Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study

Åse Hagen Morsund, Hanne Ellekjær, Arne Gramstad et al. · Stroke Research and Treatment · 2019 · 14 citations · Full text